glp 1 and anxiety GLP-1 Anxiety: Clinical Insights (public) ANXIETY AND DEPRESSION ON A

glucagon receptor activation stimulates -oxidation of fatty acids, reducing hepatic lipid content, while GLP-1 enhances systemic insulin sensitivity and decreases lipolysis in adipose tissue, thereby indirectly reducing hepatic fat influx (51)

Beyond CagriSema, Novo Nordisk is advancing amycretin-based therapies , targeting dual gut hormones to amplify weight loss effects

Ozempic (semaglutide) and Mounjaro (tirzepatide) are related medications approved for type 2 diabetes, not weight management

Anker SD, Butler J, Filippatos G et al (2021) Empagliflozin in heart failure with a preserved ejection fraction

Remote Patient Monitoring for Continuous Care Remote patient monitoring is reshaping how clinicians and patients manage GLP-1 therapy: Continuous glucose monitoring (CGM): CGM devices seamlessly integrate with apps, enabling real-time adjustments to therapy

For type 2 diabetes management , GLP-1 receptor agonists are typically considered long-term treatments